Central Wisconsin Mental Health Associates, Sc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1699 Scholfield Avenue Suite 119/120, Schofield, WI 54476 Phone: 715-212-6209 |
Vivent Health Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1105 Grand Ave, Suite 1, Schofield, WI 54476 Phone: 715-355-6867 Fax: 715-355-0640 |
Mind And Body Solutions Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 219 Ross Ave Ste 100, Schofield, WI 54476 Phone: 715-297-4635 Fax: 715-298-0749 |
Attic Correctional Servcies Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1699 Schofield Ave Ste 116, Schofield, WI 54476 Phone: 715-355-0671 |
News Archive
Scientists have discovered that testing the levels of certain proteins in blood samples can predict whether a person at risk of psychosis is likely to develop a psychotic disorder years later.
Young men who believe that happiness declines with age are more likely to engage in risky health behaviors such as binge drinking. Their misguided negative view of the aging process may act as a disincentive to behave 'sensibly' and encourage them to make the most of the present in anticipation of 'miserable' old age.
Strike a chord please, especially in light of the BMJ's article on Tuesday about the ineffectiveness of the flu vaccine for elderly last year - just wanted to make you also aware of the ultimate surface protection against viruses like H1N1, plus all the proliferating superbugs.
The largest meta-analysis so far of Mindfulness-Based Cognitive Therapy (MBCT) for recurrent depression has found that MBCT is an effective treatment option that can help prevent the recurrence of major depression. The study used anonymised individual patient data from nine randomized trials of MBCT. It suggests that for the millions of people who suffer recurrent depression it provides a treatment choice and an alternative or addition to other approaches such as maintenance anti-depressants.
Mylan Inc. today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on May 17, 2010, to holders of preferred stock of record as of May 1, 2010.
› Verified 4 days ago